Product Information

BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE is a generic product labeled by Sandoz Inc., priced at $0.9513 per EA under NDC 00781227001. Its NADAC has been published 106 times since Nov 6, 2024.

FDA first approved this application on Oct 11, 1985. Its Orange Book therapeutic-equivalence code is AA.

BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE

Butalbital, aspirin, and caffeine
$0.9513per EA
DEA Schedule CIII

Strength

325; 50; 40 mg/1; mg/1; mg/1

Manufacturer

Sandoz Inc.

NDC

00781227001

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA086996

FDA Approved

10/11/1985

TE Code

AA

On Market Since

9/3/2024

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Barbiturate
Barbiturates
Central Nervous System Stimulant
Central Nervous System Stimulation
Cyclooxygenase Inhibitors
Decreased Platelet Aggregation
Decreased Prostaglandin Production
Methylxanthine
Nonsteroidal Anti-inflammatory Drug
Platelet Aggregation Inhibitor
Xanthines

Price Statistics

The NADAC for BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE has been published 106 times since Nov 6, 2024, and over the history we have for it it has risen 26.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.9513 per EA
All-time high$1.0486 (Sep 10, 2025)
All-time low$0.3623 (Nov 20, 2024)
52-week high$0.9890
52-week low$0.9482
Median price$0.9765
Average price$0.9200
Largest weekly change+59.7% (Dec 18, 2024)
Weeks tracked106
Tracking sinceNov 6, 2024

Price History

1W

0.0%

1M

+0.3%

3M

-2.2%

6M

-2.0%

1Y

-5.8%

3Y

N/A

5Y

N/A

All

+26.9%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE, manufactured by Sandoz Inc., is $0.9513 per EA (NDC 00781227001), effective Nov 11, 2026.

How has the price of BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE has risen 26.9%. It has been tracked across 106 weekly CMS publications since Nov 6, 2024.

What are the highest and lowest recorded NADAC prices for BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE?

Since Nov 6, 2024, the NADAC for BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE has ranged from a low of $0.3623 (Nov 20, 2024) to a high of $1.0486 (Sep 10, 2025), with a median of $0.9765 per EA.

Are there cheaper alternatives to BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE?

BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE (NDC 00781227001) is labeled by Sandoz Inc., and CMS classifies it as a generic product.